Venlafaxine News and Research

RSS

Venlafaxine is an antidepressant drug that is being evaluated for the treatment of hot flashes in women who have breast cancer.

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

Dutch study finds SSRIs significantly alleviate post-COVID syndrome symptoms, offering promising treatment avenues and shedding light on neurobiological mechanisms at play.

5 Nov 2023

New category of depression identified

Scientists at Stanford Medicine conducted a study describing a new category of depression -; labeled the cognitive biotype -; which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.

23 Jun 2023

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Diabetic neuropathy refers to nerve damage due to diabetes and it may lead to pain and numbness, most often in the hands and feet. To help neurologists and other doctors determine the best treatment for people with diabetic neuropathy, the American Academy of Neurology (AAN) has issued a guideline on oral and topical treatments for painful diabetic neuropathy.

28 Dec 2021

Introducing deuterium makes drugs to have a longer effect

Hydrogen (abbreviated "H") is the lightest of all elements. It usually consists only of a positively charged proton and a negatively charged electron and is also called protium in this form. But there are also two heavier hydrogen isotopes, deuterium and tritium.

24 Dec 2021

Older people taking anxiety drugs and antidepressants more likely to suffer postoperative delirium

Older people taking a drug used to treat anxiety and insomnia – nitrazepam – as well as those on antidepressants, are twice as likely to suffer postoperative delirium after hip and knee surgery, a new Australian study has found.

9 Dec 2021

Study provides an overview of neonatal withdrawal signs following late in utero exposure to SSRIs

Neonatal withdrawal signs have been documented in newborns of mothers treated with antidepressants and are known as a cause of neonatal morbidity.

19 May 2021

Fluoxetine (Prozac) performs strongly in vitro against SARS-CoV-2 (including mutants)

Researchers from Finland, to expand on these studies, tested some of these drugs against the new SARS-CoV-2 variants. The study is published on the preprint server bioRxiv.

24 Mar 2021

An overview of withdrawal syndromes following discontinuation of psychotropic drugs

The current issue of Psychotherapy and Psychosomatics reports an article that analyzes the data that are available on what may happen when psychotropic drugs are discontinued.

24 Sep 2020

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

As out-of-pocket costs go up for drugs for the neurologic disorders Alzheimer's disease, peripheral neuropathy and Parkinson's disease, people are less likely to take the drugs as often as their doctors prescribed, according to a study funded by the American Academy of Neurology and published in the February 19, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Feb 2020

Researchers study the effects of antidepressants to identify the least harmful drugs

About one in ten women in Québec will suffer from depression during pregnancy. Without treatment, the illness carries risks for both mother and child.

8 Jan 2020

New study shows link between antidepressant use and gestational diabetes mellitus

A study has found a link between the use of antidepressants and the development of gestational diabetes mellitus (GDM) in pregnant women.

2 Oct 2019

Study sheds new light on long-term treatment with antidepressant drugs

A new study published in the current issue of Psychotherapy and Psychosomatics sheds new light on long-term studies with antidepressant drugs.

11 Apr 2019

Metabolic Syndrome could make it harder for older adults to respond to antidepressant therapy

Researchers suspect that having Metabolic Syndrome makes it harder for older adults to respond to therapies for depression.

11 Jan 2018

Antidepressants used for chronic pain relief come with significant side effects

Chronic pain negatively impacts a person's quality of life. Often, over the counter pain medication, such as ibuprofen or aspirin, are ineffective in alleviating chronic pain. In these instances, a surprising choice is often a drug used to treat an entirely different condition - depression.

5 Sep 2017

Venlafaxine News and Research

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

New category of depression identified

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Introducing deuterium makes drugs to have a longer effect

Older people taking anxiety drugs and antidepressants more likely to suffer postoperative delirium

Study provides an overview of neonatal withdrawal signs following late in utero exposure to SSRIs

Fluoxetine (Prozac) performs strongly in vitro against SARS-CoV-2 (including mutants)

An overview of withdrawal syndromes following discontinuation of psychotropic drugs

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Researchers study the effects of antidepressants to identify the least harmful drugs

New study shows link between antidepressant use and gestational diabetes mellitus

Study sheds new light on long-term treatment with antidepressant drugs

Metabolic Syndrome could make it harder for older adults to respond to antidepressant therapy

Antidepressants used for chronic pain relief come with significant side effects

Older people treated with electroconvulsive therapy for depression may not get relief from insomnia

Study explores precision psychiatry approaches to improve outcomes for patients with depression

Personalized approach to pharmacotherapy may provide advances in treatment of panic disorders

Antidepressant use during pregnancy could increase risk of birth defects in baby, study reveals

Personal fish calculator reveals safety of seafood

Most antidepressants are ineffective at treating children and teens, study shows

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News